HIMS Slides Over 25% After NVO Sues Company Over Generic GLP-1 Pills

Legal issues hits Hims & Hers (HIMS). Novo Nordisk (NVO) filed a lawsuit against the company over allegedly selling unapproved Wegovy and Ozempic weight loss drugs. Marley Kayden takes investors through the details and the stark sell-off shedding weight off HIMS stock. Prosper Trading Academy's Charles Moon takes investors through an example options trade navigating the current selling action.

Morning Trade Live

09 Feb 2026

SHARE

Schwab Network's Newsletters

Daily insights for every investor